Publisher： Future Medicine
Founded in： 2012
Total resources： 6
E-ISSN： 2045-0915
ISSN： 2045-0907
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
CNS Oncology
Menu
First-line bevacizumab for glioblastoma: what do recent Trail results mean for future treatment?
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.
Access to resources
Recommend
Emerging methods for disease monitoring in malignant gliomas
By Ambady Prakash,Bettegowda Chetan,Holdhoff Matthias in (2013)
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation
By Rooney Jessica W,Laack Nadia N in (2013)
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.The unfolded protein response in glioblastomas: passing the stress test
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.Cancer stem cells: moving past the controversy
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.Molecular prognostic factors in glioblastoma: state of the art and future challenges
By Xavier-Magalhães Ana,Nandhabalan Meera,Jones Chris,Costa Bruno M in (2013)
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.By Kahramancetin Nesibe,Tihan Tarik in (2013)
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.What is the best way to evaluate clinical target volume for radiotherapy of brain tumors?
By Fiorentino Alba,Pedicini Piernicola,Caivano Rocchina,Fusco Vincenzo in (2013)
CNS Oncology , Vol. 2, Iss. 6, 2013-11 , pp.
Previous
Next